Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 134

1.

Cost effectiveness of amoxicillin for lower respiratory tract infections in primary care: an economic evaluation accounting for the cost of antimicrobial resistance.

Oppong R, Smith RD, Little P, Verheij T, Butler CC, Goossens H, Coenen S, Moore M, Coast J.

Br J Gen Pract. 2016 Jul 11. pii: bjgpsep-2016-66-650-oppong-fl-p. [Epub ahead of print]

PMID:
27402969
2.

Impact of amoxicillin therapy on resistance selection in patients with community-acquired lower respiratory tract infections: a randomized, placebo-controlled study.

Malhotra-Kumar S, Van Heirstraeten L, Coenen S, Lammens C, Adriaenssens N, Kowalczyk A, Godycki-Cwirko M, Bielicka Z, Hupkova H, Lannering C, Mölstad S, Fernandez-Vandellos P, Torres A, Parizel M, Ieven M, Butler CC, Verheij T, Little P, Goossens H; GRACE study group.

J Antimicrob Chemother. 2016 Jun 26. pii: dkw234. [Epub ahead of print]

PMID:
27353466
3.

Corrigendum to "The global threat of antimicrobial resistance: science for intervention" [New Microbes New Infect 6 (2015): 22-29].

Roca I, Akova M, Baquero F, Carlet J, Cavaleri M, Coenen S, Cohen J, Findlay D, Gyssens I, Heuer OE, Kahlmeter G, Kruse H, Laxminarayan R, Liébana E, López-Cerero L, MacGowan A, Martins M, Rodríguez-Baño J, Rolain JM, Segovia C, Sigauque B, Tacconelli E, Wellington E, Vila J.

New Microbes New Infect. 2015 Sep 10;8:175. doi: 10.1016/j.nmni.2015.09.004. eCollection 2015 Nov.

4.

Discrepancies between qualitative and quantitative evaluation of randomised controlled trial results: achieving clarity through mixed methods triangulation.

Tonkin-Crine S, Anthierens S, Hood K, Yardley L, Cals JW, Francis NA, Coenen S, van der Velden AW, Godycki-Cwirko M, Llor C, Butler CC, Verheij TJ, Goossens H, Little P; GRACE INTRO/CHAMP consortium.

Implement Sci. 2016 May 12;11(1):66. doi: 10.1186/s13012-016-0436-0.

5.

Improving Care And Research Electronic Data Trust Antwerp (iCAREdata): a research database of linked data on out-of-hours primary care.

Colliers A, Bartholomeeusen S, Remmen R, Coenen S, Michiels B, Bastiaens H, Van Royen P, Verhoeven V, Holmgren P, De Ruyck B, Philips H.

BMC Res Notes. 2016 May 4;9(1):259. doi: 10.1186/s13104-016-2055-x.

6.

Clinical impact of five large-scale screening projects for chronic hepatitis B in Chinese migrants in the Netherlands.

Coenen S, van Meer S, Vrolijk JM, Richter C, van Erpecum KJ, Mostert MC, Veldhuijzen IK, Reijnders JG, van Soest H, Dirksen K, Drenth JP, Koene RP, Bosschart M, Friederich P, Ter Borg MJ, Daemen RH, Arends JE, Verhagen MA, Schout C, Spanier BW.

Liver Int. 2016 Mar 22. doi: 10.1111/liv.13125. [Epub ahead of print]

PMID:
27001619
7.

Identifying predictors of low adherence in patients with inflammatory bowel disease.

Coenen S, Weyts E, Ballet V, Noman M, Van Assche G, Vermeire S, Van Emelen J, Ferrante M.

Eur J Gastroenterol Hepatol. 2016 May;28(5):503-7. doi: 10.1097/MEG.0000000000000570.

PMID:
26760588
8.

Environmental triggers of acute myocardial infarction: results of a nationwide multiple-factorial population study.

Claeys MJ, Coenen S, Colpaert C, Bilcke J, Beutels P, Wouters K, Legrand V, Van Damme P, Vrints C.

Acta Cardiol. 2015 Dec;70(6):693-701. doi: 10.2143/AC.70.6.3120182.

9.

FOXP3 can modulate TAL1 transcriptional activity through interaction with LMO2.

Fleskens V, Mokry M, van der Leun AM, Huppelschoten S, Pals CE, Peeters J, Coenen S, Cardoso BA, Barata JT, van Loosdregt J, Coffer PJ.

Oncogene. 2015 Dec 21. doi: 10.1038/onc.2015.481. [Epub ahead of print]

PMID:
26686090
10.

Amoxicillin for clinically unsuspected pneumonia in primary care: subgroup analysis.

Teepe J, Little P, Elshof N, Broekhuizen BD, Moore M, Stuart B, Butler CC, Hood K, Ieven M, Coenen S, Goossens H, Verheij TJ; GRACE consortium.

Eur Respir J. 2016 Jan;47(1):327-30. doi: 10.1183/13993003.00611-2015. Epub 2015 Nov 5. No abstract available.

PMID:
26541522
11.

Staphylococcus aureus, Including Meticillin-Resistant Staphylococcus aureus, among General Practitioners and Their Patients: A Cross-Sectional Study.

Michiels B, Appelen L, Franck B, den Heijer CD, Bartholomeeusen S, Coenen S.

PLoS One. 2015 Oct 12;10(10):e0140045. doi: 10.1371/journal.pone.0140045. eCollection 2015.

12.

Smoking behaviour and knowledge of the health effects of smoking in patients with inflammatory bowel disease.

De Bie C, Ballet V, Hendriks N, Coenen S, Weyts E, Van Assche G, Vermeire S, Ferrante M.

Aliment Pharmacol Ther. 2015 Dec;42(11-12):1294-302. doi: 10.1111/apt.13423. Epub 2015 Oct 4.

PMID:
26435040
13.

Prevalence, diagnosis, and disease course of pertussis in adults with acute cough: a prospective, observational study in primary care.

Teepe J, Broekhuizen BD, Ieven M, Loens K, Huygen K, Kretzschmar M, de Melker H, Butler CC, Little P, Stuart B, Coenen S, Goossens H, Verheij TJ; GRACE consortium.

Br J Gen Pract. 2015 Oct;65(639):e662-7. doi: 10.3399/bjgp15X686917.

14.

Antibiotic Exposure and Other Risk Factors for Antimicrobial Resistance in Nasal Commensal Staphylococcus aureus: An Ecological Study in 8 European Countries.

van Bijnen EM, Paget J, de Lange-de Klerk ES, den Heijer CD, Versporten A, Stobberingh EE, Goossens H, Schellevis FG; collaboration with the APRES Study Team.

PLoS One. 2015 Aug 11;10(8):e0135094. doi: 10.1371/journal.pone.0135094. eCollection 2015.

15.

Validity of a clinical model to predict influenza in patients presenting with symptoms of lower respiratory tract infection in primary care.

van Vugt SF, Broekhuizen BD, Zuithoff NP, van Essen GA, Ebell MH, Coenen S, Ieven M, Lammens C, Goossens H, Butler CC, Hood K, Little P, Verheij TJ; GRACE Consortium.

Fam Pract. 2015 Aug;32(4):408-14. doi: 10.1093/fampra/cmv039. Epub 2015 Jun 4.

PMID:
26045544
16.

The global threat of antimicrobial resistance: science for intervention.

Roca I, Akova M, Baquero F, Carlet J, Cavaleri M, Coenen S, Cohen J, Findlay D, Gyssens I, Heuer OE, Kahlmeter G, Kruse H, Laxminarayan R, Liébana E, López-Cerero L, MacGowan A, Martins M, Rodríguez-Baño J, Rolain JM, Segovia C, Sigauque B, Tacconelli E, Wellington E, Vila J.

New Microbes New Infect. 2015 Apr 16;6:22-9. doi: 10.1016/j.nmni.2015.02.007. eCollection 2015 Jul. Review. Erratum in: New Microbes New Infect. 2015 Nov;8:175.

17.

Agreement on urgency assessment between secretaries and general practitioners: an observational study in out-of-hours general practice service in Belgium.

Philips H, Van Bergen J, Huibers L, Colliers A, Bartholomeeusen S, Coenen S, Remmen R.

Acta Clin Belg. 2015 Oct;70(5):309-14. doi: 10.1179/2295333715Y.0000000017. Epub 2015 Mar 30.

PMID:
25819448
18.

Systemic antimycotic and antifungal use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe.

Adriaenssens N, Uka V, Versporten A, Bolokhovets G, Ghazaryan L, Abilova V, Pyshnik G, Spasojevic T, Korinteli I, Kambaralieva B, Cizmovic L, Carp A, Radonjic V, Maqsudova N, Alkan A, Coenen S, Pedersen HB, Sautenkova N, Goossens H; WHO/Europe-ESAC Project Group.

J Antimicrob Chemother. 2015 Jul;70(7):2173-5. doi: 10.1093/jac/dkv064. Epub 2015 Mar 22. No abstract available.

19.

Metagenomic analysis of the impact of nitrofurantoin treatment on the human faecal microbiota.

Vervoort J, Xavier BB, Stewardson A, Coenen S, Godycki-Cwirko M, Adriaenssens N, Kowalczyk A, Lammens C, Harbarth S, Goossens H, Malhotra-Kumar S.

J Antimicrob Chemother. 2015 Jul;70(7):1989-92. doi: 10.1093/jac/dkv062. Epub 2015 Mar 12.

20.

Collateral damage from oral ciprofloxacin versus nitrofurantoin in outpatients with urinary tract infections: a culture-free analysis of gut microbiota.

Stewardson AJ, Gaïa N, François P, Malhotra-Kumar S, Delémont C, Martinez de Tejada B, Schrenzel J, Harbarth S, Lazarevic V; SATURN WP1 and WP3 Study Groups.

Clin Microbiol Infect. 2015 Apr;21(4):344.e1-11. doi: 10.1016/j.cmi.2014.11.016. Epub 2014 Nov 25.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk